000 | 01227 a2200301 4500 | ||
---|---|---|---|
005 | 20250518080445.0 | ||
264 | 0 | _c20201111 | |
008 | 202011s 0 0 eng d | ||
022 | _a1545-4304 | ||
024 | 7 |
_a10.1146/annurev-pharmtox-010919-023356 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSantoro, Bina | |
245 | 0 | 0 |
_aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders. _h[electronic resource] |
260 |
_bAnnual review of pharmacology and toxicology _c01 2020 |
||
300 |
_a109-131 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels _xchemistry |
650 | 0 | 4 |
_aNervous System Diseases _xdrug therapy |
650 | 0 | 4 |
_aNeurons _xmetabolism |
650 | 0 | 4 | _aProtein Isoforms |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xmetabolism |
700 | 1 | _aShah, Mala M | |
773 | 0 |
_tAnnual review of pharmacology and toxicology _gvol. 60 _gp. 109-131 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1146/annurev-pharmtox-010919-023356 _zAvailable from publisher's website |
999 |
_c30496610 _d30496610 |